Drugs / GSK1492903A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00435396 | Feb 2007 → Aug 2008 | cytomegalovirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1492903A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00435396 ↗ |
| Modality | Vaccine | “this CMV candidate vaccine” NCT00435396 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT00435396 ↗ |